Cargando…
Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy
SIMPLE SUMMARY: Ovarian high-grade serous cancer (HGSC), the most common and the deadliest subtype of epithelial ovarian cancer, is characterized by frequent mutations in the TP53 tumor suppressor gene, encoding for the p53 protein in nearly 100% of cases. This makes p53 the focus of many studies tr...
Autores principales: | Saleh, Aya, Perets, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304959/ https://www.ncbi.nlm.nih.gov/pubmed/34298679 http://dx.doi.org/10.3390/cancers13143465 |
Ejemplares similares
-
Concurrent isolated retroperitoneal HGSC and STIC defined by somatic mutation analysis: a case report
por: Suda, Kazuaki, et al.
Publicado: (2019) -
Multi-Omic Analysis of Two Common P53 Mutations: Proteins Regulated by Mutated P53 as Potential Targets for Immunotherapy
por: Vadakekolathu, Jayakumar, et al.
Publicado: (2022) -
The Role of Tumor Protein 53 Mutations in Common Human Cancers and Targeting the Murine Double Minute 2–P53 Interaction for Cancer Therapy
por: Hamzehloie, Tayebeh, et al.
Publicado: (2012) -
Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability
por: McDermott, Jason E., et al.
Publicado: (2020) -
Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability
por: McDermott, Jason E., et al.
Publicado: (2020)